109 related articles for article (PubMed ID: 2026874)
1. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
Patek PQ; Lin Y
J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
[TBL] [Abstract][Full Text] [Related]
2. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
Patek PQ; Lin Y; Collins JL; Cohn M
J Immunol; 1986 Jan; 136(2):741-5. PubMed ID: 3941271
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms.
Patek PQ; Lin Y; Collins JL
J Immunol; 1987 Mar; 138(5):1641-6. PubMed ID: 3805728
[TBL] [Abstract][Full Text] [Related]
4. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
Begovic M; Herberman R; Gorelik E
Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
[TBL] [Abstract][Full Text] [Related]
5. Humans express natural cytotoxic (NC) cell activity that is similar to murine NC cell activity.
Collins JL; Kao MS; Patek PQ
J Immunol; 1987 Jun; 138(12):4180-4. PubMed ID: 3584975
[TBL] [Abstract][Full Text] [Related]
6. Differences in the tumor necrosis factor-alpha-mediated lysis by fixed natural cytotoxic cells and fixed cytotoxic macrophages.
Vanderslice WE; Collins JL
J Immunol; 1991 Jan; 146(1):156-61. PubMed ID: 1984442
[TBL] [Abstract][Full Text] [Related]
7. Tumor growth in vivo selects for resistance to tumor necrosis factor.
Lattime EC; Stutman O
J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
[TBL] [Abstract][Full Text] [Related]
8. Resistance of Ha-ras oncogene-induced progressor tumor variants to tumor necrosis factor and interferon-gamma.
Fernandez A; Chen PW; Aggarwal BB; Ananthaswamy HN
Lymphokine Cytokine Res; 1992 Apr; 11(2):79-85. PubMed ID: 1581420
[TBL] [Abstract][Full Text] [Related]
9. Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor.
Richards AL; Dennert G; Pluznik DH; Takagaki Y; Djeu JY
Nat Immun Cell Growth Regul; 1989; 8(2):76-88. PubMed ID: 2761550
[TBL] [Abstract][Full Text] [Related]
10. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
Xiang J; Chen Y; Moyana T
Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha is not the sole mediator of WEHI-164 tumour cell killing in natural cytotoxicity.
Clarke GR; Shirzadeh H; Pang G; Beagley KW; Burton RC; Smart YC
Cytokine; 1997 Apr; 9(4):254-62. PubMed ID: 9112334
[TBL] [Abstract][Full Text] [Related]
12. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
13. Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo.
Vanhaesebroeck B; Mareel M; Van Roy F; Grooten J; Fiers W
Cancer Res; 1991 Apr; 51(8):2229-38. PubMed ID: 2009541
[TBL] [Abstract][Full Text] [Related]
14. Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells.
Monastra G; Cabrelle A; Zambon A; Rosato A; Macino B; Collavo D; Zanovello P
Cell Immunol; 1996 Jul; 171(1):102-10. PubMed ID: 8660844
[TBL] [Abstract][Full Text] [Related]
15. Mediation of mouse natural cytotoxic activity by tumour necrosis factor.
Ortaldo JR; Mason LH; Mathieson BJ; Liang SM; Flick DA; Herberman RB
Nature; 1986 Jun 12-18; 321(6071):700-2. PubMed ID: 3520339
[TBL] [Abstract][Full Text] [Related]
16. Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis.
Vanhaesebroeck B; Decoster E; Van Ostade X; Van Bladel S; Lenaerts A; Van Roy F; Fiers W
J Immunol; 1992 May; 148(9):2785-94. PubMed ID: 1374099
[TBL] [Abstract][Full Text] [Related]
17. An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis.
Lin Y; Collins JL; Patek PQ; Cohn M
J Immunol; 1983 Sep; 131(3):1154-9. PubMed ID: 6604090
[TBL] [Abstract][Full Text] [Related]
18. Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets.
Lopez-Cepero M; Garcia-Sanz JA; Herbert L; Riley R; Handel ME; Podack ER; Lopez DM
J Immunol; 1994 Apr; 152(7):3333-41. PubMed ID: 8144919
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
Morimoto H; Safrit JT; Bonavida B
J Immunol; 1991 Oct; 147(8):2609-16. PubMed ID: 1918981
[TBL] [Abstract][Full Text] [Related]
20. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
Liddil JD; Dorr RT; Scuderi P
Cancer Res; 1989 May; 49(10):2722-8. PubMed ID: 2713856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
